Current status and future prospects of PARP inhibitor clinical trials in ovarian cancer
Xuan Jiang, Weihua Li, Xiaoying Li, Huimin Bai, Zhenyu ZhangDepartment of Obstetrics and Gynecology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People’s Republic of ChinaAbstract: Poly (ADP-ribose) polymerase (PARP) inhibitors are a class of targeted agents for the treatm...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2019-05-01
|
| coleção: | Cancer Management and Research |
| Assuntos: | |
| Acesso em linha: | https://www.dovepress.com/current-status-and-future-prospects-of-parp-inhibitor-clinical-trials--peer-reviewed-article-CMAR |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|